Virtual Event | January 21, 2026

Advancements In Targeted LNP Therapy

Source: Advancing RNA

We’re still striving to deliver mRNA-LNPs to cells/tissue types that go beyond the liver. Outside of exploring different lipid combinations to expand mRNA-LNPs’ deliverability to new tissues, this discussion featuring Dominik Witzigmann, John Zuris, and Sujit Jain investigated the industry’s push toward active delivery to improve targeting, as well as other advancements being made to improve LNP development, quality, & deliverability.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)